These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28212334)

  • 1. Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector.
    Meier AF; Suter M; Schraner EM; Humbel BM; Tobler K; Ackermann M; Laimbacher AS
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.
    Laimbacher AS; Esteban LE; Castello AA; Abdusetir Cerfoglio JC; Argüelles MH; Glikmann G; D'Antuono A; Mattion N; Berois M; Arbiza J; Hilbe M; Schraner EM; Seyffert M; Dresch C; Epstein AL; Ackermann M; Fraefel C
    Mol Ther; 2012 Sep; 20(9):1810-20. PubMed ID: 22713696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
    Liu X; Yang T; Sun QM; Sun MS
    Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
    Lappalainen S; Tamminen K; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles.
    Johansson E; Istrate C; Charpilienne A; Cohen J; Hinkula J; Poncet D; Svensson L; Johansen K
    Vaccine; 2008 Feb; 26(6):778-85. PubMed ID: 18191310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector.
    Taylor TJ; Diaz F; Colgrove RC; Bernard KA; DeLuca NA; Whelan SPJ; Knipe DM
    Virology; 2016 Sep; 496():186-193. PubMed ID: 27336950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus virus-like particles (RV-VLPs) vaccines: An update.
    Changotra H; Vij A
    Rev Med Virol; 2017 Nov; 27(6):. PubMed ID: 29048711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSV-1 amplicon vectors as genetic vaccines.
    Laimbacher AS; Fraefel C
    Methods Mol Biol; 2014; 1144():99-115. PubMed ID: 24671679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
    Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries.
    Otero CE; Langel SN; Blasi M; Permar SR
    PLoS Pathog; 2020 Nov; 16(11):e1009010. PubMed ID: 33211756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSV-1 Amplicon Vectors as Genetic Vaccines.
    Meier AF; Laimbacher AS
    Methods Mol Biol; 2020; 2060():111-130. PubMed ID: 31617175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice.
    Zhou B; Zhang Y; Wang X; Dong J; Wang B; Han C; Yu J; Li D
    Vaccine; 2010 Aug; 28(37):6021-7. PubMed ID: 20637305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.
    Azevedo MP; Vlasova AN; Saif LJ
    Expert Rev Vaccines; 2013 Feb; 12(2):169-81. PubMed ID: 23414408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice.
    Maier EA; Weage KJ; Guedes MM; Denson LA; McNeal MM; Bernstein DI; Moore SR
    Vaccine; 2013 Dec; 32(1):48-53. PubMed ID: 24200975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colostrum from cows immunized with a veterinary vaccine against bovine rotavirus displays enhanced in vitro anti-human rotavirus activity.
    Civra A; Altomare A; Francese R; Donalisio M; Aldini G; Lembo D
    J Dairy Sci; 2019 Jun; 102(6):4857-4869. PubMed ID: 30981494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus immune responses and correlates of protection.
    Angel J; Franco MA; Greenberg HB
    Curr Opin Virol; 2012 Aug; 2(4):419-25. PubMed ID: 22677178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.